cjun inhibitor Search Results


cjun inhibitor  (Bio-Techne corporation)
94
Bio-Techne corporation cjun inhibitor
Cjun Inhibitor, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cjun inhibitor/product/Bio-Techne corporation
Average 94 stars, based on 1 article reviews
cjun inhibitor - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier
mtmet ap1 inhibitors  (TargetMol)
91
TargetMol mtmet ap1 inhibitors
Mtmet Ap1 Inhibitors, supplied by TargetMol, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mtmet ap1 inhibitors/product/TargetMol
Average 91 stars, based on 1 article reviews
mtmet ap1 inhibitors - by Bioz Stars, 2026-04
91/100 stars
  Buy from Supplier
rabbit anti cjun  (Cell Signaling Technology Inc)
98
Cell Signaling Technology Inc rabbit anti cjun
KEY RESOURCES TABLE
Rabbit Anti Cjun, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti cjun/product/Cell Signaling Technology Inc
Average 98 stars, based on 1 article reviews
rabbit anti cjun - by Bioz Stars, 2026-04
98/100 stars
  Buy from Supplier
sirnas for gsk3b  (Ribobio co)
90
Ribobio co sirnas for gsk3b
KEY RESOURCES TABLE
Sirnas For Gsk3b, supplied by Ribobio co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sirnas for gsk3b/product/Ribobio co
Average 90 stars, based on 1 article reviews
sirnas for gsk3b - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
anti-cjun antibody sc-44  (Santa Cruz Biotechnology)
90
Santa Cruz Biotechnology anti-cjun antibody sc-44
A: Electrophoretic Mobility Shift Assay (EMSA) showing protein binding to the (+52/+60) PAK3 promoter region. Lane 1 shows the presence of a DNA/protein complex when the (+52/+60) PAK3 promoter radioactively-labelled oligomer was incubated with protein cell lysate of Rat1a-J4 cells treated with doxycycline. This DNA/protein complex could be competed for with unlabelled (+52/+60) wild-type (WT) oligomers (lane 2), but not with a mutated (+52/+60) sequence oligomer (lane 3). The second panel shows supershifted complexes using <t>anti-cJun</t> (lane 4), -JunB (lane 5) and –JunD (lane 6) antibodies. <t>B:</t> <t>Chromatin</t> Immunoprecipitation Assay (ChIP) showing cJun binding to the (+52/+60) PAK3 promoter region. Rat1a-J4 cells were treated with doxycycline for 48 hrs, after which DNA and protein complexes were cross-linked and pulled down with an anti-cJun antibody. RT-PCR amplification off the pulled-down chromatin showed cJun binding to the (+52/+60) PAK3 promoter region in the presence of doxycycline.
Anti Cjun Antibody Sc 44, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-cjun antibody sc-44/product/Santa Cruz Biotechnology
Average 90 stars, based on 1 article reviews
anti-cjun antibody sc-44 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
cjun n-terminal kinase (jnk) inhibitor sp600125  (Enzo Biochem)
90
Enzo Biochem cjun n-terminal kinase (jnk) inhibitor sp600125
A: Electrophoretic Mobility Shift Assay (EMSA) showing protein binding to the (+52/+60) PAK3 promoter region. Lane 1 shows the presence of a DNA/protein complex when the (+52/+60) PAK3 promoter radioactively-labelled oligomer was incubated with protein cell lysate of Rat1a-J4 cells treated with doxycycline. This DNA/protein complex could be competed for with unlabelled (+52/+60) wild-type (WT) oligomers (lane 2), but not with a mutated (+52/+60) sequence oligomer (lane 3). The second panel shows supershifted complexes using <t>anti-cJun</t> (lane 4), -JunB (lane 5) and –JunD (lane 6) antibodies. <t>B:</t> <t>Chromatin</t> Immunoprecipitation Assay (ChIP) showing cJun binding to the (+52/+60) PAK3 promoter region. Rat1a-J4 cells were treated with doxycycline for 48 hrs, after which DNA and protein complexes were cross-linked and pulled down with an anti-cJun antibody. RT-PCR amplification off the pulled-down chromatin showed cJun binding to the (+52/+60) PAK3 promoter region in the presence of doxycycline.
Cjun N Terminal Kinase (Jnk) Inhibitor Sp600125, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cjun n-terminal kinase (jnk) inhibitor sp600125/product/Enzo Biochem
Average 90 stars, based on 1 article reviews
cjun n-terminal kinase (jnk) inhibitor sp600125 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
pd98059, an inhibitor of extracellular signal-regulated kinase (erk) mapk  (Millipore)
90
Millipore pd98059, an inhibitor of extracellular signal-regulated kinase (erk) mapk
A: Electrophoretic Mobility Shift Assay (EMSA) showing protein binding to the (+52/+60) PAK3 promoter region. Lane 1 shows the presence of a DNA/protein complex when the (+52/+60) PAK3 promoter radioactively-labelled oligomer was incubated with protein cell lysate of Rat1a-J4 cells treated with doxycycline. This DNA/protein complex could be competed for with unlabelled (+52/+60) wild-type (WT) oligomers (lane 2), but not with a mutated (+52/+60) sequence oligomer (lane 3). The second panel shows supershifted complexes using <t>anti-cJun</t> (lane 4), -JunB (lane 5) and –JunD (lane 6) antibodies. <t>B:</t> <t>Chromatin</t> Immunoprecipitation Assay (ChIP) showing cJun binding to the (+52/+60) PAK3 promoter region. Rat1a-J4 cells were treated with doxycycline for 48 hrs, after which DNA and protein complexes were cross-linked and pulled down with an anti-cJun antibody. RT-PCR amplification off the pulled-down chromatin showed cJun binding to the (+52/+60) PAK3 promoter region in the presence of doxycycline.
Pd98059, An Inhibitor Of Extracellular Signal Regulated Kinase (Erk) Mapk, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pd98059, an inhibitor of extracellular signal-regulated kinase (erk) mapk/product/Millipore
Average 90 stars, based on 1 article reviews
pd98059, an inhibitor of extracellular signal-regulated kinase (erk) mapk - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
cjun n-terminal kinase (jnk) inhibitor (sp600125, purity>98  (Beyotime)
90
Beyotime cjun n-terminal kinase (jnk) inhibitor (sp600125, purity>98
A: Electrophoretic Mobility Shift Assay (EMSA) showing protein binding to the (+52/+60) PAK3 promoter region. Lane 1 shows the presence of a DNA/protein complex when the (+52/+60) PAK3 promoter radioactively-labelled oligomer was incubated with protein cell lysate of Rat1a-J4 cells treated with doxycycline. This DNA/protein complex could be competed for with unlabelled (+52/+60) wild-type (WT) oligomers (lane 2), but not with a mutated (+52/+60) sequence oligomer (lane 3). The second panel shows supershifted complexes using <t>anti-cJun</t> (lane 4), -JunB (lane 5) and –JunD (lane 6) antibodies. <t>B:</t> <t>Chromatin</t> Immunoprecipitation Assay (ChIP) showing cJun binding to the (+52/+60) PAK3 promoter region. Rat1a-J4 cells were treated with doxycycline for 48 hrs, after which DNA and protein complexes were cross-linked and pulled down with an anti-cJun antibody. RT-PCR amplification off the pulled-down chromatin showed cJun binding to the (+52/+60) PAK3 promoter region in the presence of doxycycline.
Cjun N Terminal Kinase (Jnk) Inhibitor (Sp600125, Purity>98, supplied by Beyotime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cjun n-terminal kinase (jnk) inhibitor (sp600125, purity>98/product/Beyotime
Average 90 stars, based on 1 article reviews
cjun n-terminal kinase (jnk) inhibitor (sp600125, purity>98 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
sp600125  (Cell Signaling Technology Inc)
96
Cell Signaling Technology Inc sp600125
A: Electrophoretic Mobility Shift Assay (EMSA) showing protein binding to the (+52/+60) PAK3 promoter region. Lane 1 shows the presence of a DNA/protein complex when the (+52/+60) PAK3 promoter radioactively-labelled oligomer was incubated with protein cell lysate of Rat1a-J4 cells treated with doxycycline. This DNA/protein complex could be competed for with unlabelled (+52/+60) wild-type (WT) oligomers (lane 2), but not with a mutated (+52/+60) sequence oligomer (lane 3). The second panel shows supershifted complexes using <t>anti-cJun</t> (lane 4), -JunB (lane 5) and –JunD (lane 6) antibodies. <t>B:</t> <t>Chromatin</t> Immunoprecipitation Assay (ChIP) showing cJun binding to the (+52/+60) PAK3 promoter region. Rat1a-J4 cells were treated with doxycycline for 48 hrs, after which DNA and protein complexes were cross-linked and pulled down with an anti-cJun antibody. RT-PCR amplification off the pulled-down chromatin showed cJun binding to the (+52/+60) PAK3 promoter region in the presence of doxycycline.
Sp600125, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sp600125/product/Cell Signaling Technology Inc
Average 96 stars, based on 1 article reviews
sp600125 - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier

Image Search Results


KEY RESOURCES TABLE

Journal: Cell reports

Article Title: YAP/TAZ Activation Drives Uveal Melanoma Initiation and Progression

doi: 10.1016/j.celrep.2019.03.021

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: Rabbit anti-cJun , Cell Signaling , Cat# 9165; RRID:AB_2130165.

Techniques: Virus, Plasmid Preparation, Recombinant, Protease Inhibitor, Reporter Assay, Software

A: Electrophoretic Mobility Shift Assay (EMSA) showing protein binding to the (+52/+60) PAK3 promoter region. Lane 1 shows the presence of a DNA/protein complex when the (+52/+60) PAK3 promoter radioactively-labelled oligomer was incubated with protein cell lysate of Rat1a-J4 cells treated with doxycycline. This DNA/protein complex could be competed for with unlabelled (+52/+60) wild-type (WT) oligomers (lane 2), but not with a mutated (+52/+60) sequence oligomer (lane 3). The second panel shows supershifted complexes using anti-cJun (lane 4), -JunB (lane 5) and –JunD (lane 6) antibodies. B: Chromatin Immunoprecipitation Assay (ChIP) showing cJun binding to the (+52/+60) PAK3 promoter region. Rat1a-J4 cells were treated with doxycycline for 48 hrs, after which DNA and protein complexes were cross-linked and pulled down with an anti-cJun antibody. RT-PCR amplification off the pulled-down chromatin showed cJun binding to the (+52/+60) PAK3 promoter region in the presence of doxycycline.

Journal: PLoS ONE

Article Title: p21-Activated Kinase 3 (PAK3) Is an AP-1 Regulated Gene Contributing to Actin Organisation and Migration of Transformed Fibroblasts

doi: 10.1371/journal.pone.0066892

Figure Lengend Snippet: A: Electrophoretic Mobility Shift Assay (EMSA) showing protein binding to the (+52/+60) PAK3 promoter region. Lane 1 shows the presence of a DNA/protein complex when the (+52/+60) PAK3 promoter radioactively-labelled oligomer was incubated with protein cell lysate of Rat1a-J4 cells treated with doxycycline. This DNA/protein complex could be competed for with unlabelled (+52/+60) wild-type (WT) oligomers (lane 2), but not with a mutated (+52/+60) sequence oligomer (lane 3). The second panel shows supershifted complexes using anti-cJun (lane 4), -JunB (lane 5) and –JunD (lane 6) antibodies. B: Chromatin Immunoprecipitation Assay (ChIP) showing cJun binding to the (+52/+60) PAK3 promoter region. Rat1a-J4 cells were treated with doxycycline for 48 hrs, after which DNA and protein complexes were cross-linked and pulled down with an anti-cJun antibody. RT-PCR amplification off the pulled-down chromatin showed cJun binding to the (+52/+60) PAK3 promoter region in the presence of doxycycline.

Article Snippet: Lysates was then diluted with dilution buffer (1% Triton X-100, 2 mM EDTA, 150 mM NaCl, 20 mM Tris-Cl, pH 8.1, 1 X Complete Protease Inhibitor) and chromatin was either immunoprecipitated with or without anti-cJun antibody (sc-44 (Santa Cruz)) and treated with pre-blocked protein-A agarose beads (Merck).

Techniques: Electrophoretic Mobility Shift Assay, Protein Binding, Incubation, Sequencing, Chromatin Immunoprecipitation, Binding Assay, Reverse Transcription Polymerase Chain Reaction, Amplification